PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.160
-0.080 (-6.45%)
At close: Nov 3, 2025, 4:00 PM EST
1.160
0.00 (0.00%)
After-hours: Nov 3, 2025, 4:51 PM EST
PainReform Market Cap
PainReform has a market cap or net worth of $2.34 million as of November 3, 2025. Its market cap has increased by 52.01% in one year.
Market Cap
2.34M
Enterprise Value
-926.71K
1-Year Change
52.01%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $2.34M, a decrease of -96.66%. That is a compound annual growth rate of -48.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 2.50M | -14.95% |
| Dec 31, 2024 | 2.94M | -31.51% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
| Sep 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |